Contact Us
Aptitude Health
  • About Us
  • Axess Network
    • Life Science Companies
    • Healthcare Professionals
  • Solutions
    • Business Intelligence
    • Medical Communications
    • Medical Publications
    • Real-World Evidence
    • Promotional Services
    • Case Studies
  • Insight Reports
  • News & Events
  • Log In
    • Axess Network Members
  • Contact Us

Medical Advances

View All
View All Sign Up

Error: Your requested Widget "List Custom Taxonomy" is not in the "Widgets for Shortcodes" sidebar

  • [do_widget_area industry-news]
    • [do_widget_area smartslider_area_1]
      • [do_widget_area trm-blog]
        • [do_widget id="custom_html-6"]
        • [do_widget id="lc_taxonomy-4"]
        • [do_widget id="lc_taxonomy-3"]
        • [do_widget id="archives-4"]
      • [do_widget_area trm-oncology]
        • [do_widget_area widgets_for_shortcodes]
          • [do_widget_area wp_inactive_widgets]
            • [do_widget id="search-2"]
            • [do_widget id="recent-posts-2"]
            • [do_widget id="recent-comments-2"]
            • [do_widget id="archives-2"]
            • [do_widget id="categories-2"]
            • [do_widget id="meta-2"]
            • [do_widget id="custom_html-5"]
            • [do_widget id="lc_taxonomy-2"]
            • [do_widget id="archives-3"]

          Therapeutic Area

          • Acute Lymphoblastic Leukemia (ALL) (10)
          • Acute Myeloid Leukemia (AML) (14)
          • Advanced Endometrial Cancer (aEC) (2)
          • B-Cell Lymphomas (1)
          • Basal Cell Carcinoma (1)
          • Biliary tract cancer (1)
          • Biliary tract carcinoma (1)
          • Bladder Cancer (4)
          • Bone Cancer (1)
          • Brain Metastases (2)
          • Breast Cancer (44)
          • CAR T (7)
          • Castleman Disease (1)
          • Cervical Cancer (9)
          • Chronic Lymphocytic Leukemia (CLL) (11)
          • Chronic Myeloid Leukemia (CML) (3)
          • Classical Hodgkin Lymphoma (CHL) (1)
          • Colorectal Cancer (11)
          • CRC Malignancies (4)
          • Cutaneous T-cell lymphoma (CTCL) (1)
          • Differentiated Thyroid Cancer (DTC) (1)
          • DLBCL (6)
          • Endometrial Cancer (5)
          • Esophageal squamous cell carcinoma (1)
          • Follicular lymphoma (4)
          • Gastric Cancers (1)
          • Gastrointestinal Malignancies (GI) (17)
          • GEJ adenocarcinoma (1)
          • Genitourinary Malignancies (GU) (20)
          • Glioma (2)
          • Gynecologic Malignancies (10)
          • Head & Neck (3)
          • Hematologic Malignancies (1)
          • Hepatocellular carcinoma (HCC) (6)
          • Hodgkin Lymphoma (5)
          • Leukemia (13)
          • Lung Cancer (19)
          • Lymphoma (15)
          • Maintenance Therapy in Acute Myeloid Leukemia (AML) (1)
          • Management of TKI Therapies (2)
          • Mantle Cell Lymphoma (MCL) (4)
          • Marginal Zone Lymphoma (MZL) (1)
          • Melanoma (12)
          • Merkel cell carcinoma (2)
          • Metastatic cancers (1)
          • Multiple Myeloma (22)
          • Myelodysplastic syndromes (2)
          • Myelodysplastic Syndromes (MDS) (9)
          • Myelofibrosis (MF) (5)
          • Myeloproliferative Neoplasms (MPN) (1)
          • Neuroendocrine Tumors (NET) (1)
          • Non-Hodgkin Lymphoma (3)
          • Non-Small-Cell Lung Carcinoma (NSCLC) (22)
          • NTRK Fusion-Positive Cancers (1)
          • Ovarian Cancer (13)
          • Pancreatic Cancer (3)
          • Ph+ ALL (1)
          • Prostate Cancer (13)
          • Renal cell cancer (RCC) (7)
          • Small Lymphocytic Lymphoma (SLL) (2)
          • Small-cell carcinoma (SCLC) (6)
          • Squamous Cell Carcinoma (2)
          • Thyroid Cancer (5)
          • Urothelial Cancer (2)
          • Urothelial carcinoma (5)
          • Veno-Occlusive Disease/Sinusoidal Obstructive Syndrome (VOD/SOS) (2)

          Categories

          • Medical Advances (177)
          • Industry Insights (90)
          • Expert Perspectives (21)
          • Aptitude Health (11)

          Archives

          • May 2025 (2)
          • April 2025 (3)
          • March 2025 (3)
          • February 2025 (7)
          • January 2025 (1)
          • December 2024 (3)
          • November 2024 (3)
          • October 2024 (2)
          • September 2024 (4)
          • August 2024 (3)
          • July 2024 (3)
          • June 2024 (3)
          • May 2024 (2)
          • April 2024 (3)
          • March 2024 (4)
          • February 2024 (3)
          • January 2024 (3)
          • December 2023 (3)
          • November 2023 (3)
          • October 2023 (3)
          GEJ adenocarcinoma
          Medical Advances

          PD-1 or PD-L1 Inhibitors for Treatment of GEJ Adenocarcinoma

          By Aptitude Health

          By Aptitude Health

          Aptitude Health logo
          Read more
          AI and machine learning image
          Medical Advances

          Accelerated Drug Repurposing With AI and Machine Learning

          By Aptitude Health

          By Aptitude Health

          Aptitude Health logo
          Read more
          Drugs
          Medical Advances

          Most FDA and EMA Oncology Drug Approvals in Q1 2025 Were New Indications for Biologics and Biosimilars

          By Aptitude Health

          By Aptitude Health

          Aptitude Health logo
          Read more
          Scanning electron micrograph of a colon cancer cell
          Medical Advances

          Improved Survival With Dual-Agent Immunotherapy in Metastatic Colorectal Cancer Subtypes

          By Aptitude Health

          By Aptitude Health

          Aptitude Health logo
          Read more
          New Resource to Help Scientists Better Classify Cancer Subtypes
          Medical Advances

          New Resource to Help Scientists Better Classify Cancer Subtypes

          By Aptitude Health

          By Aptitude Health

          Aptitude Health logo
          Read more
          Promising New Research in the Treatment of Cancer Cachexia
          Medical Advances

          Promising New Research in the Treatment of Cancer Cachexia

          By Aptitude Health

          By Aptitude Health

          Aptitude Health logo
          Read more
          Mixed Results With Dual Immune Checkpoint Inhibition for Aggressive Thyroid Carcinoma
          Medical Advances

          Mixed Results With Dual Immune Checkpoint Inhibition for Aggressive Thyroid Carcinoma

          By Aptitude Health

          By Aptitude Health

          Aptitude Health logo
          Read more
          Differences in cancer rates among adults show increases among each successive generation
          Medical Advances

          Differences in Cancer Rates Among Adults Show Increases Among Each Successive Generation

          By Aptitude Health

          By Aptitude Health

          Aptitude Health logo
          Read more
          The Link Between High-volume Centers and Survival Improvements for Patients Undergoing Esophagectomy
          Medical Advances

          The Link Between High-Volume Centers and Survival Improvements for Patients Undergoing Esophagectomy

          By Aptitude Health

          By Aptitude Health

          Aptitude Health logo
          Read more
          Fear of Cancer Recurrence Is Prevalent Among Adult Survivors of Childhood Cancer
          Medical Advances

          Fear of Cancer Recurrence

          By Aptitude Health

          By Aptitude Health

          Aptitude Health logo
          Read more

          Posts navigation

          Older posts

          Therapeutic Area

          • Acute Lymphoblastic Leukemia (ALL) (10)
          • Acute Myeloid Leukemia (AML) (14)
          • Advanced Endometrial Cancer (aEC) (2)
          • B-Cell Lymphomas (1)
          • Basal Cell Carcinoma (1)
          • Biliary tract cancer (1)
          • Biliary tract carcinoma (1)
          • Bladder Cancer (4)
          • Bone Cancer (1)
          • Brain Metastases (2)
          • Breast Cancer (44)
          • CAR T (7)
          • Castleman Disease (1)
          • Cervical Cancer (9)
          • Chronic Lymphocytic Leukemia (CLL) (11)
          • Chronic Myeloid Leukemia (CML) (3)
          • Classical Hodgkin Lymphoma (CHL) (1)
          • Colorectal Cancer (11)
          • CRC Malignancies (4)
          • Cutaneous T-cell lymphoma (CTCL) (1)
          • Differentiated Thyroid Cancer (DTC) (1)
          • DLBCL (6)
          • Endometrial Cancer (5)
          • Esophageal squamous cell carcinoma (1)
          • Follicular lymphoma (4)
          • Gastric Cancers (1)
          • Gastrointestinal Malignancies (GI) (17)
          • GEJ adenocarcinoma (1)
          • Genitourinary Malignancies (GU) (20)
          • Glioma (2)
          • Gynecologic Malignancies (10)
          • Head & Neck (3)
          • Hematologic Malignancies (1)
          • Hepatocellular carcinoma (HCC) (6)
          • Hodgkin Lymphoma (5)
          • Leukemia (13)
          • Lung Cancer (19)
          • Lymphoma (15)
          • Maintenance Therapy in Acute Myeloid Leukemia (AML) (1)
          • Management of TKI Therapies (2)
          • Mantle Cell Lymphoma (MCL) (4)
          • Marginal Zone Lymphoma (MZL) (1)
          • Melanoma (12)
          • Merkel cell carcinoma (2)
          • Metastatic cancers (1)
          • Multiple Myeloma (22)
          • Myelodysplastic syndromes (2)
          • Myelodysplastic Syndromes (MDS) (9)
          • Myelofibrosis (MF) (5)
          • Myeloproliferative Neoplasms (MPN) (1)
          • Neuroendocrine Tumors (NET) (1)
          • Non-Hodgkin Lymphoma (3)
          • Non-Small-Cell Lung Carcinoma (NSCLC) (22)
          • NTRK Fusion-Positive Cancers (1)
          • Ovarian Cancer (13)
          • Pancreatic Cancer (3)
          • Ph+ ALL (1)
          • Prostate Cancer (13)
          • Renal cell cancer (RCC) (7)
          • Small Lymphocytic Lymphoma (SLL) (2)
          • Small-cell carcinoma (SCLC) (6)
          • Squamous Cell Carcinoma (2)
          • Thyroid Cancer (5)
          • Urothelial Cancer (2)
          • Urothelial carcinoma (5)
          • Veno-Occlusive Disease/Sinusoidal Obstructive Syndrome (VOD/SOS) (2)

          Categories

          • Medical Advances (177)
          • Industry Insights (90)
          • Expert Perspectives (21)
          • Aptitude Health (11)

          Archives

          • May 2025 (2)
          • April 2025 (3)
          • March 2025 (3)
          • February 2025 (7)
          • January 2025 (1)
          • December 2024 (3)
          • November 2024 (3)
          • October 2024 (2)
          • September 2024 (4)
          • August 2024 (3)
          • July 2024 (3)
          • June 2024 (3)
          • May 2024 (2)
          • April 2024 (3)
          • March 2024 (4)
          • February 2024 (3)
          • January 2024 (3)
          • December 2023 (3)
          • November 2023 (3)
          • October 2023 (3)
          Aptitude Health

          We are the global market leader in evidence-based solutions for life science companies seeking to identify, develop, and commercialize oncology and hematology innovations. With a proven track record of success, we transform the world’s growing scientific and clinical knowledge into better patient outcomes. The expertise of our team is backed by unparalleled access to global disease-state experts and healthcare professionals, making Aptitude Health the strategic partner of choice for the world’s most successful life science companies.

          United States

          5901-B Peachtree Dunwoody Road Suite 415, Atlanta, GA 30328, US
          Tel: +1 678 892 1365

          Europe

          Laan van Nieuw Oost-Indië 133 F, 2593 BM The Hague, the Netherlands
          Tel: +31 70 30 67 200

          United Kingdom

          6th Floor, 2 Kingdom Street London W2 6BD, United Kingdom

          About Us
          Careers
          Axess Network
          Life Science Companies
          Healthcare Professionals
          Solutions
          Business Intelligence
          Medical Communications
          Medical Publications
          Real-World Evidence
          Promotional Services
          Case Studies
          Insight Reports
          News & Events

          Log In
          Axess Network Members
          Contact Us

          Newsletter Signup
          Copyright © 2025 Aptitude Health. All Rights Reserved. APTITUDE HEALTH® is a federally registered service mark of Aptitude Health Holdings, LLC.
          Terms of Use Privacy Policy Cookie Policy Careers Sitemap
          Back To Top

          Aptitude Health makes use of cookies to analyze and improve our website user experience and for marketing purposes. By continuing or by clicking on the “Accept” button, you consent to the use of cookies and the processing of personal data obtained in this way. Learn more about our Terms of Use, Cookie Policy, and Privacy Policy.

          Aptitude Health
          Powered by  GDPR Cookie Compliance
          Privacy Overview

          This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

          Strictly Necessary Cookies

          Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings. We also use functional cookies to track down misuse of our websites and services, for example by registering the number of consecutive failed login attempts. We do not need your consent for the use of functional cookies, since there is no privacy impact.

          If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

          3rd Party Cookies

          This website uses Google Analytics, Vimeo Analytics, and LinkedIn Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

          Keeping this cookie enabled helps us to improve our website.

          Please enable Strictly Necessary Cookies first so that we can save your preferences!

          Cookie Policy

          More information about our Cookie Policy